COMET's path, and the new biologicals in rheumatoid arthritis
- PMID: 18635257
- DOI: 10.1016/S0140-6736(08)61001-6
COMET's path, and the new biologicals in rheumatoid arthritis
Comment on
-
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.Lancet. 2008 Aug 2;372(9636):375-82. doi: 10.1016/S0140-6736(08)61000-4. Epub 2008 Jul 16. Lancet. 2008. PMID: 18635256 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical